Ustekinumab in Treatment of Refractory Paediatric Crohn Disease

J Pediatr Gastroenterol Nutr. 2016 Mar;62(3):e30. doi: 10.1097/MPG.0000000000000608.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Crohn Disease / drug therapy*
  • Humans
  • Psoriasis
  • Treatment Outcome
  • Ustekinumab*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Ustekinumab